{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,23]],"date-time":"2026-08-23T22:14:31Z","timestamp":1787523271495,"version":"build-2736575974"},"reference-count":32,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2017,2,1]],"date-time":"2017-02-01T00:00:00Z","timestamp":1485907200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100001837","name":"Estonian Science Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001837","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.com.au","clinicalkey.es","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Seminars in Arthritis and Rheumatism"],"published-print":{"date-parts":[[2017,2]]},"DOI":"10.1016\/j.semarthrit.2016.08.017","type":"journal-article","created":{"date-parts":[[2016,9,2]],"date-time":"2016-09-02T07:40:22Z","timestamp":1472802022000},"page":"444-450","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"title":["High mobility group box protein 1\u2014A prognostic marker for structural joint damage in 10-year follow-up of patients with juvenile idiopathic arthritis"],"prefix":"10.1016","volume":"46","author":[{"given":"Rille","family":"Pullerits","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hanna","family":"Schierbeck","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karin","family":"Uibo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hille","family":"Liivam\u00e4gi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sirje","family":"Tarraste","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tiina","family":"Talvik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erik","family":"Sundberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chris","family":"Pruunsild","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.semarthrit.2016.08.017_bib1","first-page":"1520","article-title":"Worldwide prevalence of juvenile arthritis why does it vary so much?","volume":"29","author":"Manners","year":"2002","journal-title":"J Rheumatol"},{"key":"10.1016\/j.semarthrit.2016.08.017_bib2","doi-asserted-by":"crossref","first-page":"2138","DOI":"10.1016\/S0140-6736(11)60244-4","article-title":"Juvenile idiopathic arthritis","volume":"377","author":"Prakken","year":"2011","journal-title":"Lancet"},{"key":"10.1016\/j.semarthrit.2016.08.017_bib3","doi-asserted-by":"crossref","first-page":"1260","DOI":"10.1136\/ard.2010.133033","article-title":"Juvenile idiopathic arthritis: state of the art and future perspectives","volume":"69","author":"Martini","year":"2010","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.semarthrit.2016.08.017_bib4","first-page":"390","article-title":"International League of Associations for Rheumatology classification of juvenile idiopathic arthritis: second revision, Edmonton, 2001","volume":"31","author":"Petty","year":"2004","journal-title":"J Rheumatol"},{"key":"10.1016\/j.semarthrit.2016.08.017_bib5","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1038\/nrrheum.2011.222","article-title":"HMGB1: a multifunctional alarmin driving autoimmune and inflammatory disease","volume":"8","author":"Harris","year":"2012","journal-title":"Nat Rev Rheumatol"},{"key":"10.1016\/j.semarthrit.2016.08.017_bib6","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1002\/art.10859","article-title":"High mobility group box chromosomal protein 1 plays a role in the pathogenesis of rheumatoid arthritis as a novel cytokine","volume":"48","author":"Taniguchi","year":"2003","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.semarthrit.2016.08.017_bib7","doi-asserted-by":"crossref","first-page":"2675","DOI":"10.1002\/art.23729","article-title":"Extracellular high mobility group box chromosomal protein 1 is a coupling factor for hypoxia and inflammation in arthritis","volume":"58","author":"Hamada","year":"2008","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.semarthrit.2016.08.017_bib8","doi-asserted-by":"crossref","first-page":"210","DOI":"10.2119\/2006-00108.Goldstein","article-title":"Cholinergic anti-inflammatory pathway activity and high mobility group box-1 (HMGB1) serum levels in patients with rheumatoid arthritis","volume":"13","author":"Goldstein","year":"2007","journal-title":"Mol Med"},{"key":"10.1016\/j.semarthrit.2016.08.017_bib9","doi-asserted-by":"crossref","first-page":"1523","DOI":"10.3899\/jrheum.110091","article-title":"Serum levels of HMGB1 in postmenopausal patients with rheumatoid arthritis: associations with proinflammatory cytokines, acute-phase reactants, and clinical disease characteristics","volume":"38","author":"Pullerits","year":"2011","journal-title":"J Rheumatol"},{"key":"10.1016\/j.semarthrit.2016.08.017_bib10","doi-asserted-by":"crossref","first-page":"2598","DOI":"10.1002\/art.10540","article-title":"High mobility group box chromosomal protein 1: a novel proinflammatory mediator in synovitis","volume":"46","author":"Kokkola","year":"2002","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.semarthrit.2016.08.017_bib11","doi-asserted-by":"crossref","first-page":"1693","DOI":"10.1002\/art.11028","article-title":"High mobility group box chromosomal protein 1, a DNA binding cytokine, induces arthritis","volume":"48","author":"Pullerits","year":"2003","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.semarthrit.2016.08.017_bib12","doi-asserted-by":"crossref","first-page":"730","DOI":"10.1002\/jcp.21268","article-title":"HMGB1 is a bone-active cytokine","volume":"214","author":"Yang","year":"2008","journal-title":"J Cell Physiol"},{"key":"10.1016\/j.semarthrit.2016.08.017_bib13","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1002\/jcp.20577","article-title":"HMGB1 expression and release by bone cells","volume":"207","author":"Charoonpatrapong","year":"2006","journal-title":"J Cell Physiol"},{"key":"10.1016\/j.semarthrit.2016.08.017_bib14","doi-asserted-by":"crossref","first-page":"1039","DOI":"10.2119\/molmed.2010.00264","article-title":"Monoclonal anti-HMGB1 (high mobility group box chromosomal protein 1) antibody protection in two experimental arthritis models","volume":"17","author":"Schierbeck","year":"2011","journal-title":"Mol Med"},{"key":"10.1016\/j.semarthrit.2016.08.017_bib15","doi-asserted-by":"crossref","first-page":"1604","DOI":"10.3899\/jrheum.120987","article-title":"HMGB1 levels are increased in patients with juvenile idiopathic arthritis, correlate with early onset of disease, and are independent of disease duration","volume":"40","author":"Schierbeck","year":"2013","journal-title":"J Rheumatol"},{"key":"10.1016\/j.semarthrit.2016.08.017_bib16","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1089\/ars.2014.6039","article-title":"Characterization of the inflammatory properties of actively released HMGB1 in juvenile idiopathic arthritis","volume":"24","author":"Lundback","year":"2014","journal-title":"Antioxid Redox Signal"},{"key":"10.1016\/j.semarthrit.2016.08.017_bib17","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1186\/1546-0096-12-50","article-title":"The presence of high mobility group box-1 and soluble receptor for advanced glycation end-products in juvenile idiopathic arthritis and juvenile systemic lupus erythematosus","volume":"12","author":"Bobek","year":"2014","journal-title":"Pediatr Rheumatol Online J"},{"key":"10.1016\/j.semarthrit.2016.08.017_bib18","first-page":"649","article-title":"Prevalence and short-term outcome of juvenile idiopathic arthritis: a population-based study in Estonia","volume":"25","author":"Pruunsild","year":"2007","journal-title":"Clin Exp Rheumatol"},{"key":"10.1016\/j.semarthrit.2016.08.017_bib19","doi-asserted-by":"crossref","first-page":"1535","DOI":"10.1373\/49.9.1535","article-title":"High mobility group protein 1 (HMGB1) quantified by ELISA with a monoclonal antibody that does not cross-react with HMGB2","volume":"49","author":"Yamada","year":"2003","journal-title":"Clin Chem"},{"key":"10.1016\/j.semarthrit.2016.08.017_bib20","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1016\/j.intimp.2011.01.005","article-title":"Production of recombinant human HMGB1 and anti-HMGB1 rabbit serum","volume":"11","author":"Lin","year":"2011","journal-title":"Int Immunopharmacol"},{"key":"10.1016\/j.semarthrit.2016.08.017_bib21","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1189\/jlb.0306196","article-title":"Factors masking HMGB1 in human serum and plasma","volume":"81","author":"Urbonaviciute","year":"2007","journal-title":"J Leukoc Biol"},{"key":"10.1016\/j.semarthrit.2016.08.017_bib22","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1080\/03009740601089259","article-title":"Incidence of juvenile idiopathic arthritis in children in Estonia: a prospective population-based study","volume":"36","author":"Pruunsild","year":"2007","journal-title":"Scand J Rheumatol"},{"key":"10.1016\/j.semarthrit.2016.08.017_bib23","doi-asserted-by":"crossref","first-page":"1084","DOI":"10.1359\/jbmr.080234","article-title":"HMGB1 regulates RANKL-induced osteoclastogenesis in a manner dependent on RAGE","volume":"23","author":"Zhou","year":"2008","journal-title":"J Bone Miner Res"},{"key":"10.1016\/j.semarthrit.2016.08.017_bib24","doi-asserted-by":"crossref","first-page":"1067","DOI":"10.1084\/jem.20051947","article-title":"Regulation of osteoclast function and bone mass by RAGE","volume":"203","author":"Zhou","year":"2006","journal-title":"J Exp Med"},{"key":"10.1016\/j.semarthrit.2016.08.017_bib25","doi-asserted-by":"crossref","first-page":"5045","DOI":"10.4049\/jimmunol.162.9.5045","article-title":"Cutting edge: HLA-B27 can form a novel beta 2-microglobulin-free heavy chain homodimer structure","volume":"162","author":"Allen","year":"1999","journal-title":"J Immunol"},{"key":"10.1016\/j.semarthrit.2016.08.017_bib26","doi-asserted-by":"crossref","first-page":"6665","DOI":"10.4049\/jimmunol.163.12.6665","article-title":"Misfolding of HLA-B27 as a result of its B pocket suggests a novel mechanism for its role in susceptibility to spondyloarthropathies","volume":"163","author":"Mear","year":"1999","journal-title":"J Immunol"},{"key":"10.1016\/j.semarthrit.2016.08.017_bib27","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1038\/nature07203","article-title":"From endoplasmic-reticulum stress to the inflammatory response","volume":"454","author":"Zhang","year":"2008","journal-title":"Nature"},{"key":"10.1016\/j.semarthrit.2016.08.017_bib28","first-page":"187","article-title":"Preliminary study of high mobility group box chromosomal protein 1 (HMGB1) in ankylosing spondylitis patients","volume":"33","author":"Chen","year":"2015","journal-title":"Clin Exp Rheumatol"},{"key":"10.1016\/j.semarthrit.2016.08.017_bib29","doi-asserted-by":"crossref","first-page":"1327","DOI":"10.1007\/s00296-012-2578-y","article-title":"Elevated serum levels of high mobility group box protein 1 (HMGB1) in patients with ankylosing spondylitis and its association with disease activity and quality of life","volume":"33","author":"Oktayoglu","year":"2013","journal-title":"Rheumatol Int"},{"key":"10.1016\/j.semarthrit.2016.08.017_bib30","doi-asserted-by":"crossref","first-page":"1378","DOI":"10.1002\/art.1780330910","article-title":"Autoantibodies to nonhistone chromosomal proteins HMG-1 and HMG-2 in sera of patients with juvenile rheumatoid arthritis","volume":"33","author":"Wittemann","year":"1990","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.semarthrit.2016.08.017_bib31","first-page":"2489","article-title":"Relationship between sex and antibodies to high mobility group proteins 1 and 2 in juvenile idiopathic arthritis","volume":"27","author":"Rosenberg","year":"2000","journal-title":"J Rheumatol"},{"key":"10.1016\/j.semarthrit.2016.08.017_bib32","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1186\/s13075-015-0856-2","article-title":"Antibodies against high mobility group box protein-1 (HMGB1) versus other anti-nuclear antibody fine-specificities and disease activity in systemic lupus erythematosus","volume":"17","author":"Wirestam","year":"2015","journal-title":"Arthritis Res Ther"}],"container-title":["Seminars in Arthritis and Rheumatism"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0049017216302426?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0049017216302426?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,8,19]],"date-time":"2023-08-19T22:51:42Z","timestamp":1692485502000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0049017216302426"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,2]]},"references-count":32,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2017,2]]}},"alternative-id":["S0049017216302426"],"URL":"https:\/\/doi.org\/10.1016\/j.semarthrit.2016.08.017","relation":{},"ISSN":["0049-0172"],"issn-type":[{"value":"0049-0172","type":"print"}],"subject":[],"published":{"date-parts":[[2017,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"High mobility group box protein 1\u2014A prognostic marker for structural joint damage in 10-year follow-up of patients with juvenile idiopathic arthritis","name":"articletitle","label":"Article Title"},{"value":"Seminars in Arthritis and Rheumatism","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.semarthrit.2016.08.017","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}